What is the price-to-earnings ratio of OptiNose?
The price-earnings ratio of OptiNose is currently -3.31.
OptiNose P/E 2024
OptiNose P/E
-3.31
Ticker
OPTN
ISIN
US68404V1008
WKN
A2H5PR
As of Jul 1, 2024, OptiNose's P/E ratio was -3.31, a -16.2% change from the -3.95 P/E ratio recorded in the previous year.
The OptiNose P/E history
OptiNose Aktienanalyse
What does OptiNose do?
OptiNose Inc is a leading company in the field of nasal therapy, focused on improving the quality of life for patients with various upper respiratory tract conditions. The company was founded in 2010 and is headquartered in Yardley, Pennsylvania, USA. OptiNose developed a new therapy approach for nasal diseases based on the technology of the "Exhalation platform." This technology utilizes the patient's natural exhaling to deliver medication deep into the nasal and sinus regions where it is most needed. OptiNose Inc has patented and further developed this technology in 2009. The company's business model is based on the development and marketing of medications and medical devices that utilize the Exhalation platform technology. This innovative technology can be used to treat various upper respiratory conditions and complaints, including chronic sinusitis, allergic rhinitis, migraines, and other headache disorders. OptiNose Inc currently operates in two main business areas: therapeutic products and diagnostic and monitoring devices. Therapeutic products include various medications delivered through the Exhalation platform technology, as well as accessories such as spray devices. The diagnostic and monitoring devices include various products aimed at testing different diseases affecting the upper respiratory tract. One of OptiNose Inc's most well-known products is the XHANCE nebulizer, used to deliver inhaled medications deep into patient's nasal passages. Other important products include the OPTIMIST system, used for medication delivery to treat sinus and nasal conditions, and the Sinuva sinus implant, used for the treatment of nasal cavity narrowing and polyps. In addition, OptiNose Inc works closely with various research and development partners to develop new diagnostic and therapeutic approaches for upper respiratory tract diseases. In this way, the company is always seeking new opportunities to improve the quality of life for patients with these conditions. OptiNose Inc is a dynamic and innovative company focused on the development and marketing of advanced nasal therapy solutions. With modern technology, highly qualified personnel, and a strong focus on the needs of its patients, it will certainly continue to achieve significant success in the future. OptiNose ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/E Details
Deciphering OptiNose's P/E Ratio
The Price to Earnings (P/E) Ratio of OptiNose is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.
Year-to-Year Comparison
Assessing OptiNose's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.
Impact on Investments
The P/E ratio of OptiNose is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.
Interpreting P/E Ratio Fluctuations
Fluctuations in OptiNose’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.
Frequently Asked Questions about OptiNose Stock
How has the price-earnings ratio of OptiNose changed compared to last year?
The price-to-earnings ratio of OptiNose has increased by -16.2% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of OptiNose high compared to other companies?
Yes, the price-to-earnings ratio of OptiNose is high compared to other companies.
How does an increase in the price-earnings ratio of OptiNose affect the company?
An increase in the price-earnings ratio of OptiNose would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of OptiNose affect the company?
A decrease in the price-earnings ratio of OptiNose would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of OptiNose?
Some factors that influence the price-earnings ratio of OptiNose are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does OptiNose pay?
Over the past 12 months, OptiNose paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, OptiNose is expected to pay a dividend of 0 USD.
What is the dividend yield of OptiNose?
The current dividend yield of OptiNose is .
When does OptiNose pay dividends?
OptiNose pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of OptiNose?
OptiNose paid dividends every year for the past 0 years.
What is the dividend of OptiNose?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is OptiNose located?
OptiNose is assigned to the 'Health' sector.
Wann musste ich die Aktien von OptiNose kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of OptiNose from 7/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/1/2024.
When did OptiNose pay the last dividend?
The last dividend was paid out on 7/1/2024.
What was the dividend of OptiNose in the year 2023?
In the year 2023, OptiNose distributed 0 USD as dividends.
In which currency does OptiNose pay out the dividend?
The dividends of OptiNose are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von OptiNose
Our stock analysis for OptiNose Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of OptiNose Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
